Summary
This prediction ended on 30.06.16 with a price of €88.54. The BUY prediction by ler finished with a performance of 3.07%. ler has 50% into this predictionBayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Bayer AG | -0.090% | -0.090% | -44.730% | -40.950% |
iShares Core DAX® | 1.560% | 2.566% | 18.261% | 16.927% |
iShares Nasdaq 100 | 0.517% | 1.894% | 25.521% | 35.441% |
iShares Nikkei 225® | 1.730% | 5.631% | 18.569% | 13.063% |
iShares S&P 500 | 1.482% | 1.594% | 24.989% | 38.339% |
Comments by ler for this prediction
In the thread Bayer AG diskutieren
Kaufgelegenheit
Es gibt 2 Szenarien:
1. Die Übernahme von Monsanto klappt und das gemeinsame Geschäftsmodell funktioniert oder
2. Die Übernahme scheitert
In beiden Fällen sollte der Bayer-Kurs steigen.
Die 3. Möglichkeit einer Übernahme mit einem Scheitern des gemeinsamen Wegs sehe ich als wenig wahrscheinlich.